Login to Your Account



Taking a Switch to Cancer Cells

Controlling Means of Production Could Improve Protein Therapies

By Anette Breindl


Monday, October 3, 2011
A frequent challenge for drug developers is how to target drugs – especially cancer drug, which aim to kill their target cells – to the right cell population. But researchers at Johns Hopkins University have turned this problem on its ear: Instead of delivering drugs specifically to cancer cells, they have developed a way to make cancer cells activate prodrugs through use of molecular switches.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription